Overview
Updated 14 Jul 2026
Jeffrey Meyerhardt, MD MPH, is Senior Physician and Chief Clinical Research Officer, Dana-Farber Cancer Institute. The public record shows 1,086 publications with 53,998 citations (h-index 119), centered on Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Nutrition and Health in Aging. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 3 companies, 5 NIH-funded awards (2003–2026).
- Top research focus: Colorectal Cancer Treatments and Studies
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 46 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 411.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
Sponsor: Dana-Farber Cancer Institute
InvestigatorRecruitingNCT06565052 - Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
Sponsor: AdventHealth Translational Research Institute
InvestigatorRecruitingNCT05773144 - Physical Activity In Gastrointestinal Cancer
Sponsor: Dana-Farber Cancer Institute
InvestigatorCompletedNCT03331406
Industry payments
Updated 14 Jul 2026
3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Janssen Scientific Affairs, LLCProgram year20221 payment
- Merck Sharp & Dohme CorporationProgram year20211 payment
NIH funding
Updated 14 Jul 2026
5 NIH research awards on record, funded 2003–2026 per NIH RePORTER. The latest:
Congress activity
Updated 14 Jul 2026
140 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Abstract 5038: Associations of WCRF/AICR recommendations with survival and chemotherapy outcomes in colon cancer: CALGB/SWOG 80702 (Alliance)
AACR Annual Meeting
AACR2026Co-author - Abstract 7596: Risk factors and prediction models for colorectal cancer in older US individuals.
AACR Annual Meeting
AACR2026Co-author - Lycopene and survival in patients with stage III colon cancer: Findings from CALGB (Alliance)/SWOG 80702.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Most-cited worksby citation count (OpenAlex)
- 01Nutrition and physical activity guidelines for cancer survivors2,026 citations2012
- 02Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology1,756 citations2021
- 03Duration of Adjuvant Chemotherapy for Stage III Colon Cancer1,132 citations2018
- 04
- 05Systemic Therapy for Colorectal Cancer1,052 citations2005
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
Editorial & leadership rolesjournal and society appointments
- Co-Director
Colon and Rectal Cancer Center, Dana-Farber Cancer Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
- Project Co-Leader
Gastrointestinal Cancer SPORE, Dana-Farber/Harvard Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
Secondary affiliationsappointments beyond the home institution
- Dana-Farber/Harvard Cancer Center (DFHCC)
Member, Cancer Epidemiology research program; Member, Gastrointestinal Malignancies research program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dfhcc.harvard.edu ↗ - Brigham and Women's Hospital
Medical Oncology (Boston/Chestnut Hill, MA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physiciandirectory.brighamandwomens.org ↗
Media & interviewspress, podcasts and appearances
- Co-host
"How We Treat: Colon and Rectal Cancer" podcast (with Dr. Ronald Bleday)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →open.spotify.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.net ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dailynews.ascopubs.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/jeffrey-meyerhardt-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/jeffrey-meyerhardt-6974662a5
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
ascopost.com/videos/2019-gastrointestinal-cancers-symposium/jeffrey-meyerhardt-on-adjuvant-chemotherapy-in-colon-cancer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Spotify
open.spotify.com/show/3ZcdgQVGwt0wJesfEKp7G9
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Richardson, MD
Harvard University
- 2,062
- publications
- 172
- h-index
- 17
- trials
Pasi Janne, MD, PhD
Harvard University
- 2,385
- publications
- 163
- h-index
- 15
- trials
Steven Greenberg, MD
Harvard University
- 954
- publications
- 144
- h-index
- 9
- trials
David Scadden, MD
Harvard University
- 665
- publications
- 124
- h-index
- 4
- trials